Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00542438 · ClinicalTrials.gov registry record · NA

Home-Based Measures of Physical Activity and Body Composition

A NA study of Cardiovascular Disease, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
62
Enrollment target
1
Study location

NCT00542438: Active NA study of Cardiovascular Disease, sponsored by M.D. Anderson Cancer Center.

NCT00542438 is a NA study of Cardiovascular Disease that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 62 participants, below the 2,697-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00542438, a NA study of Cardiovascular Disease, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
62 participants
Enrollment target
1
Study location

Study Summary

The specific aim of this study is to collect preliminary data on the feasibility and validity of home-based data collection methods to measure four constructs: * Physical Activity: Real-time assessment using Ecological Momentary Assessment (EMA) and pedometers * Cardiorespiratory Fitness: Step test * Anthropometry: Waist and hip circumference measurements * Environmental Variables: Examples include density of neighborhood physical activity facilities (including gyms, parks, walking trails), crime, land use mix, and transportation variables, collected by participants using EMA.

Primary Outcome

Feasibility measured by the percentage of participants who have adequate cardiorespiratory fitness (i.e., V02 max greater than or equal to 31) to perform the step test. Researchers will consider the test feasible if greater than or equal to 75% of the participants have adequate fitness to perform the test.

Conditions Studied

Interventions

  • BEHAVIORAL Physical Activity Recall
  • BEHAVIORAL Environmental Assessments

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2007-10-09
Est. Completion 2026-05-31
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the registry record for NCT00542438 still lists

NCT00542438 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 2,697-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 2 interventions - of which Physical Activity Recall is the first listed.

NCT00542438 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00542438 about?

NCT00542438 is a clinical study titled "Home-Based Measures of Physical Activity and Body Composition". The specific aim of this study is to collect preliminary data on the feasibility and validity of home-based data collection methods to measure four constructs: * Physical Activity: Real-time assessment using Ecological Momentary Assessment (EMA) and pedometers * Cardiorespiratory Fitness: Step test...

What is the current status of trial NCT00542438?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2007-10-09. Estimated completion is 2026-05-31.

What conditions does trial NCT00542438 study?

This clinical trial studies the following conditions: Cardiovascular Disease.

What interventions are being tested in trial NCT00542438?

The interventions under investigation include: Physical Activity Recall (BEHAVIORAL), Environmental Assessments (BEHAVIORAL).

Who is sponsoring clinical trial NCT00542438?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00542438 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00542438's enrollment target sits among peer trials

62 99th of 137 higher than 39 of 137 other Cardiovascular Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00542438, the US trial registry maintained by the National Library of Medicine. NCT00542438 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.